GENEVA, SWITZERLAND / ACCESS Newswire / November 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering ...
An announcement from RELIEF THERAPEUTICS Holding ( (CH:RLF)) is now available. Relief Therapeutics and NeuroX have completed their business combination to form MindMaze Therapeutics, a company poised ...
ABOUT MINDMAZE THERAPEUTICS MindMaze Therapeutics is a Swiss-based, commercial-stage company formed in December 2025 through the business combination of RELIEF THERAPEUTICS Holding SA (Relief) and ...
(RTTNews) - Relief Therapeutics Holding SA (RLFTF, RLF.SW), a biopharmaceutical company, on Tuesday said it has published a joint presentation deck ahead of the expected mid-December 2025 closing of ...
Relief Therapeutics Holding SA / Key word(s): Patent 21-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this ...
Shareholders approve all EGM proposals related to the combination with NeuroX Business combination expected to close in December 2025 Relief to be renamed MindMaze Therapeutics Holding SA upon closing ...
Relief Therapeutics Holding SA / Key word(s): AGMEGM 14-Nov-2025 / 18:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results